4 results match your criteria: "Virgen Macarena & Virgen del Rocío University Hospitals[Affiliation]"
Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities.
Eur J Gastroenterol Hepatol
January 2015
aCIBER on Liver and Digestive Diseases (CIBERehd), Hospital Vall d'Hebron bHospital del Mar, IMIM, Universitat Autònoma de Barcelona cHospital de la Santa Creu i Sant Pau dHospital Clínic, Barcelona eCIBERehd H. La Fe, Hospital General Universitario de Castellón, Castellón fHospital Son Espases, Palma de Mallorca gCIBERehd, Hospital Universitari Germans Trias i Pujol, Badalona hCIBERehd, Hospital Carlos III iHospital Universitario 12 de Octubre jHospital Puerta del Hierro kFundación Jiménez Díaz lCIBERehd, Hospital Universitario La Princesa, Madrid mHospital de Cruces, Bizkaia nHospital Virgen Macarena oCIBERehd, Hospital Universitario de Valme, Sevilla pHospital Central de Asturias, Oviedo qHospital Universitario Fundación Alcorcón, Alcorcón rHospital Universitario de La Coruña, A Coruña sHospital Universitario Donostia, Donostia tCIBERehd, Hospital Universitario y Politécnico La Fe uHospital General Universitario de Valencia, Valencia vCIBERehd, Hospital Virgen de la Victoria, Málaga wHospital Universitario San Cecilio, Granada, Spain.
Objectives: The aim of this study was to evaluate the efficacy and safety of entecavir monotherapy in nucleos(t)ide-naive chronic hepatitis B patients and to analyse the influence of the comorbidity burden on therapy outcome.
Methods: We retrospectively analysed data from 237 nucleos(t)ide-naive chronic hepatitis B white patients treated with entecavir (0.5 mg/day) at 23 Spanish centres.
Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.
Clin Microbiol Infect
April 2014
Infectious Diseases Department, Medicine Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
A prospective, multicentre, population-based surveillance programme for Candida bloodstream infections was implemented in five metropolitan areas of Spain to determine its incidence and the prevalence of antifungal resistance, and to identify predictors of death. Between May 2010 and April 2011, Candida isolates were centralized to a reference laboratory for species identification by DNA sequencing and for susceptibility testing by EUCAST reference procedure. Prognostic factors associated with early (0-7 days) and late (8-30 days) death were analysed using logistic regression modelling.
View Article and Find Full Text PDF[Consequences of obesity in outcomes after cardiac surgery. Analysis of ARIAM registry].
Med Clin (Barc)
August 2013
Unidad de Cuidados Intensivos, Hospital Carlos Haya, Málaga, España.
Background And Objetive: Obesity is a disease that affects a large part of the population and has been associated with worse outcomes after cardiac surgery. The aim of our study is to evaluate the consequences of obesity related to postoperative complications, hospital length of stay and mortality.
Methods: Observational, prospective, multicenter study of patients included in ARIAM registry of adult cardiac surgery between March 2008 to March 2011.
Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide.
Osteoporos Int
June 2011
Department of Clinical Biochemistry, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Unlabelled: We report the changes in biochemical markers of bone formation during the first 6 months of teriparatide therapy in postmenopausal women with osteoporosis according to previous antiresorptive treatment. Prior therapy does not adversely affect the response to teriparatide treatment. Similar bone markers levels are reached after 6 months of treatment.
View Article and Find Full Text PDF